Research suggests that prior authorization has negative effects on patients with cancer and oncology providers.

The FDA has approved Imuldosa, a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

Unemployment, neurological deficit, and some treatments increase the likelihood adult survivors of childhood cancer retain a fear of recurrence or SMN.

The MVA-BN vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems effective in adolescents.

Native Hawaiian and Pacific Islander adults have a high rate of cardiovascular disease mortality, according to study findings.

The per member per month (PMPM) health care costs for members with insomnia were 4 to 6 times higher than those without insomnia.

For disease-specific survival in malignant adnexal tumors of the skin, Mohs micrographic surgery is superior to wide local excision and no treatment.

Psilocybin-assisted psychotherapy can help patients with cancer with a range of psychiatric symptoms, according to a recent study.

Precocious puberty is associated with approximately 2-fold greater odds of hidradenitis suppurativa, regardless of patient-specific characteristics.

ON101 is more effective than absorbent dressings for the treatment of diabetic foot ulcers among patients with risk factors that delay wound healing.

Despite having a worse clinicopathogic profile, patients with CHNM had a better response to ICI therapy when compared with patients with CMOS.

Two different doses of sebetralstat significantly reduced anxiety compared with placebo during hereditary angioedema (HAE) attacks.